Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Company News
As of June 10, 2025 • 2:30 AM ET
| Date/Time | Source | News Release |
|---|---|---|
| 06/05/2025 07:00 AM EDT | Newsfile | Theralase Annual General Meeting |
| 05/30/2025 07:00 AM EDT | Newsfile | Theralase(R) 1Q2025 Financial Statements |
| 05/29/2025 04:30 PM EDT | Newsfile | CORRECTION FROM SOURCE: Theralase to Present Groundbreaking Research at ASTRO 2025 |
| 05/28/2025 07:00 AM EDT | Newsfile | Theralase to Present Groundbreaking Research at ASTRO 2025 |
| 05/20/2025 07:00 AM EDT | Newsfile | Theralase Provides Corporate Update |
| 05/05/2025 07:00 AM EDT | Newsfile | Theralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological Association |
| 04/28/2025 07:00 AM EDT | Newsfile | Theralase Discovers New Mechanism of Action of Lead Drug |
| 04/14/2025 04:22 PM EDT | Newsfile | Theralase(R) Closes Non-Brokered Private Placement |
| 04/10/2025 07:00 AM EDT | Newsfile | Ruvidar More Effective in the Treatment of Herpes than FDA-Approved Treatments |
| 04/07/2025 07:00 AM EDT | Newsfile | Ruvidar Demonstrates 7 Year Complete Response |
Additional News
As of June 10, 2025 • 2:30 AM ET
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.